共 4 条
- [1] DRUG BIOEQUIVALENCE - RECOMMENDATIONS FROM DRUG BIOEQUIVALENCE STUDY PANEL TO OFFICE OF TECHNOLOGY ASSESSMENT, CONGRESS OF UNITED-STATES JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1974, 2 (05): : 433 - 466
- [4] Estimating cost-effectiveness of Concerta OROS in attention-deficit/hyperactivity disorder (ADHD) - Adapting the Canadian coordinating office for health technology assessment's (CCOHTA) economic model of methylphenidate immediate release versus behavioural interventions from a parent's perspective VALUE IN HEALTH, 2002, 5 (06) : 517 - 517